China's formal crackdown and U-turn on the use of the cannabis-derived ingredient cannabidiol (CBD) in cosmetics production, while not surprising, represents a significant blow to the fledgling market that had quadrupled in the past year. Drug regulator, the National Medical Products Administration (NMPA), last week banned the use of CBD - a compound found in the cannabis plant - in...